Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
59,770,937
-
Share change
-
-1,480,770
-
Total reported value
-
$1,417,172,672
-
Put/Call ratio
-
7.7%
-
Price per share
-
$23.71
-
Number of holders
-
161
-
Value change
-
-$63,863,484
-
Number of buys
-
68
-
Number of sells
-
112
Institutional Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q3 2014
As of 30 Sep 2014,
IMPAX LABORATORIES INC - COM (IPXL) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,770,937 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Invesco Ltd., State Street Corp, Slate Path Capital LP, FMR LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., and Ameriprise Financial Inc.
This page lists
161
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.